New Data On Cancer Diagnostic Presented By Arbor Vita
Nov 21st 2008Drug InformationCervical Cancer
Arbor Vita Corporation (AVC), a privately held biopharmaceutical company, presented new data on its rapid, point-of-care prototype HPV test with a high positive predictive value for cervical cancer and pre-cancer. Targeted for use throughout the developing world, this diagnostic test is being developed in partnership with PATH.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
